Table 2.

Study participant characteristics: demographic, anthropometric, and clinical information.

Information	Details	Values (All)	Values (S0)	Values (S3)
Number of patients		478	221	257
Sex, number of patients	Male/female	271/207	89/132	182/75
Age, years	Mean ± standard deviation	40.97 ± 10.61	40.70 ± 10.32	41.22 ± 10.86
	(Range)	(18 to 70)	(18 to 70)	(18 to 70)
	Median	40	40	40
BMI, $\mathrm{kg}/{\mathrm{m}}^2$	Mean ± standard deviation	23.60 ± 3.55	21.40 ± 2.51	25.49 ±3.21
	(Range)	(17 to 40)	(17 to 29)	(18 to 40)
	Median	23	21	26
Disease history, number of patients	HBV	341	164	177
	Elevated ALT/ASTa	101	39	62
	HCV	14	6	8
	Other	12	3	9
	Healthy volunteers	10	9	1
Steatosis grade, number of patients (based on Fibroscan CAP ranges)	S0	221	221	0
	S3	257	0	257
Concurrent fibrosis/cirrhosis (based on Fibroscan kPa ranges)		0	0	0

^aALT, alanine transaminase; AST, aspartate aminotransferase.